September 13, 2017 Licensing, IP, and Legal Life Science Tools PR/Corporate Product Launch

Cellular Dynamics International Presents Annual iForum Meetings Focused on New Applications and Uses for Differentiated Human iPS Cells

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Astrocytes iCell DopaNeurons iCell GABANeurons iCell GlutaNeurons iCell Motor Neurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts... Read more

September 12, 2017 Life Science Tools

The Genome 10K (G10K) Consortium Selects 10x Genomics for Next Phase of their Vertebrate Genome Project (VGP)

– 10x Genomics’ Chromium™ de novo Assembly Solution Adopted to Generate High Quality Reference Genome Assemblies using Linked-Reads Data – PLEASANTON, Calif.—September 12, 2017—10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, announced today that the pioneering Chromium™ de novoAssembly Solution will be used for the generation of high-quality genome assemblies to... Read more

September 12, 2017 Life Science Tools PR/Corporate

Paragon Genomics Raises $8m in Oversubscribed Series A Financing Round

HAYWARD, Calif., Sept. 12, 2017 — Paragon Genomics, a life science company dedicated to improving critical upfront target enrichment and library preparation workflows for Next-Generation Sequencing (NGS), closed its oversubscribed Series A funding round which was led by Cowin Venture Capital and Fosun Industrial Co., Limited. Additional investors were Cloudstone Venture, HEDA Ventures, and Wisemont Capital. “With this funding, we will develop additional NGS... Read more

September 12, 2017 Life Science Tools PR/Corporate

DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology

September 12, 2017 06:00 AM Pacific Daylight Time PARIS–(BUSINESS WIRE)–Synthetic DNA manufacturer DNA Script has today announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures with additional investments from M Ventures, the corporate venture arm of Merck KGaA, Darmstadt, Germany, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest... Read more

September 7, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Provides Families a Novel, Personalized Approach to Managing their Health WALTHAM, Massachusetts – September 7, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction... Read more

September 7, 2017 Informatics & Software Life Science Tools PR/Corporate

WuXi NextCODE Completes $240 Million Series B Financing

Investment from leading technology and healthcare investors will accelerate the growth of the global platform for genomic data The global platform aims to empower institutions and individuals to realize the full value of their genomic data – to benefit human health and contribute to advancing precision medicine SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Sept. 7, 2017 /PRNewswire/ — WuXi NextCODE,... Read more

September 6, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools

Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project

Cambridge, UK, September 06, 2017 Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensed Congenica’s Sapientia™ software platform to perform analysis of whole-exome sequencing data and... Read more

September 5, 2017 Clinical Research/Diagn. Life Science Tools Product Launch

New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings

New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings Analysis shows that high quality BRAHMS PCT (procalcitonin) assays are reliable tools to assist in the safe management of patients with suspected bacterial infection and sepsis HENNIGSDORF, Germany, Sept. 5, 2017 /PRNewswire/ — A new study, recently... Read more

September 1, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies... Read more

August 31, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Seegene accelerates ‘Project 100’ by securing 30 co-development partners

2017.08.31 Seoul, Korea, 2017/08/31 – Seegene, the world’s leading developer of multiplex molecular technologies and assays, announced that it has recently signed collaborative contracts with 30 general hospitals and reference laboratories across 15 nations for the co-development of ‘Project 100’ products. Contracting parties are mostly the largest commercial labs in the country, university hospitals, and... Read more